Literature DB >> 6295610

Adenoid cystic carcinoma of the salivary gland. Sustained complete response to chemotherapy.

G T Budd, C W Groppe.   

Abstract

A patient developed widely metastatic adenoid cystic carcinoma of the parotid gland after several local recurrences. A complete regression of pleural, pulmonary parenchymal, cutaneous, and bone metastases was seen following therapy with 5-fluorouracil, Adriamycin, and mitomycin C. This is the second complete response to chemotherapy reported for a patient with metastatic adenoid cystic carcinoma of salivary gland origin. Both complete responses and several partial responses have followed treatment with Adriamycin, suggesting that this drug is active in the disease.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6295610     DOI： 10.1002/1097-0142(19830215)51:4<589::aid-cncr2820510405>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  11 in total

1.  Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study.

Authors:  Moran Amit; Yoav Binenbaum; Kanika Sharma; Naomi Ramer; Ilana Ramer; Abib Agbetoba; Joelle Glick; Xinjie Yang; Delin Lei; Kristine Bjørndal; Christian Godballe; Thomas Mücke; Klaus-Dietrich Wolff; Dan Fliss; André M Eckardt; Chiara Copelli; Enrico Sesenna; Frank Palmer; Ian Ganly; Snehal Patel; Ziv Gil
Journal:  Head Neck       Date:  2014-07-24       Impact factor: 3.147

Review 2.  Chemotherapeutic management of head and neck cancer.

Authors:  M Al-Sarraf
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  An unusual case of exclusive liver metastases from adenoid cystic carcinoma of the submandibular gland: a role for surgery? Report of a case.

Authors:  Genoveffa Balducci; Andrea Sagnotta; Mirko Muroni; Claudio Cacchi; Alberto D'Amato
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

4.  Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands.

Authors:  Gun Yoon; Hyun-Soo Kim; Yoo-Young Lee; Tae-Joong Kim; Chel Hun Choi; Sang Yong Song; Byoung-Gie Kim; Duk-Soo Bae; Jeong-Won Lee
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 5.  Lung, bone, skeletal muscles and cutaneous metastases from adenoid cystic carcinoma of the parotid gland: a case report and review of the literature.

Authors:  Vuslat Yurut-Caloglu; Murat Caloglu; Filiz Ozyilmaz; Mert Saynak; Rusen Cosar-Alas; Hakan Karagol; Gulden Bayir-Angin; Cem Uzal
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 6.  Chemotherapy for cranial base tumors.

Authors:  H E Jacob
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Accumulated cytotoxicity of CDK inhibitor dinaciclib with first-line chemotherapy drugs in salivary adenoid cystic carcinoma cells.

Authors:  Laijun Xu; Lingzhi Li; Jun Zhang; Wenping Cai; Shouliang Zhao; Shangfeng Liu
Journal:  Odontology       Date:  2019-09-16       Impact factor: 2.634

Review 8.  Management of salivary gland carcinomas - a review.

Authors:  Xiaoli Wang; Yijun Luo; Minghuan Li; Hongjiang Yan; Mingping Sun; Tingyong Fan
Journal:  Oncotarget       Date:  2017-01-17

9.  A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands.

Authors:  A S Jones; D E Phillips; J A Cook; T R Helliwell
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

10.  Adenoid cystic carcinoma of the parotid metastasizing to liver: case report.

Authors:  K Harish; S R Mangala Gouri
Journal:  BMC Cancer       Date:  2004-07-30       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.